Updates from NIH Agencies on Funding Strategies.   If you see more guidance, please send it my way.  Thanks.

NCI


Message to Grantees About NCI Funding and Grant Support for FY2013 May 7, 2013


  *   Reductions in ongoing (non-competing) grants (about 6%), centers and other research programs (6.5%), and research and development contracts (8.5%)


Varmus Memo<http://www.cancer.gov/aboutnci/director/messages/nci-budget-FY2013>


NIDA


NIDA Funding Strategy for Fiscal Year 2013, revised May 2013


  *   Non-Competing Continuation Awards:
  *   Consistent with overall NIH policy every effort will be made to keep the average size of awards constant at FY 2012 levels.
  *   Non-competing awards will be issued without cost of living/inflationary adjustments in FY 2013.
  *   FY 2013 awards that have already been issued will be revised to adjust the award level.
  *   R13 and RSDAs continuation awards will be funded at committed, including co-funds.
  *   Modular and Non-modular continuation awards will be funded at approximately 96% of committed levels, including co-funds.
  *   NSRAs (Fs and Ts) will be issued at the FY 2012 stipend levels.
         NIDA Funding Strategy<http://www.drugabuse.gov/funding/funding-priorities/nida-funding-strategy/nida-funding-strategy-fiscal-year-2013>

NIGMS


Budget Outlook May 8, 2013


  *   Inflationary increases will be discontinued for all competing and noncompeting awards (both modular and nonmodular).
  *   All noncompeting grants will be reduced by 3.5% from the Fiscal Year 2013 committed level.
  *   Commitments in Fiscal Year 2014 and beyond will remain unchanged.
  *   Overall average costs for competing RPGs will be at approximately the Fiscal Year 2012 level. Inflationary increases for future-year commitments will be discontinued.
  *   Fiscal Year 2013 noncompeting awards that have already been issued at a reduced level will be revised upward to reflect the 3.5% reduction.
  *   New investigators on R01-equivalent awards will be supported at a success rate equivalent to that of established investigators submitting new (Type 1) R01-equivalent applications.
  *   We anticipate funding 758 competing RPGs, with a success rate of 18% (see comparisons for previous years).


NIGMS Feedback Loop<https://loop.nigms.nih.gov/>


NIMH


FY 2013 Funding Strategy for Research Grants


  *   Non-Competing Continuation Grants: For Research Project Grants (RPGs),Centers, and Other Research Mechanisms (excluding Research Career Development):
  *   Modular Grants: Modular grant awards will be reduced -4% from their FY 2013 committed levels.
  *   Commitments for continuation awards in FY 2014 and beyond will remain unchanged at this time.
  *   Non-Modular Grants: Non-modular grant awards will be reduced -4% from their FY 2013 committed levels. Commitments for continuation awards in FY 2014 and beyond will remain unchanged at this time.


NIMH Funding<http://www.nimh.nih.gov/funding/grants/fy-2013-funding-strategy-for-research-grants.shtml>


Jill Mortali
Director, Office of Sponsored Projects
Dartmouth College
11 Rope Ferry Road
Hanover NH 0375
603-646-0678


########################################################################

To unsubscribe from the ROUNDTABLE list, click the following link:
https://listserv.dartmouth.edu/scripts/wa.exe?SUBED1=ROUNDTABLE